HOUSE DOCKET, NO. 4255 FILED ON: 4/4/2023
HOUSE . . . . . . . . . . . . . . . No. 4070
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Kristin E. Kassner and Bruce E. Tarr
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act designating April 5 as Okur-Chung Neurodevelopmental Syndrome Awareness Day.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Kristin E. Kassner | 2nd Essex | 4/4/2023 |
Bruce E. Tarr | First Essex and Middlesex | 4/4/2023 |
Jillian Kavanaugh | 33 Crescent Road, Hamilton, MA 01982 | 4/4/2023 |
Samantha Montaño | 15th Suffolk | 4/10/2023 |
Bud L. Williams | 11th Hampden | 4/14/2023 |
Vanna Howard | 17th Middlesex | 7/2/2023 |
HOUSE DOCKET, NO. 4255 FILED ON: 4/4/2023
HOUSE . . . . . . . . . . . . . . . No. 4070
By Representative Kassner of Hamilton and Senator Tarr, a joint petition (subject to Joint Rule 12) of Kristin E. Kassner, Bruce E. Tarr and others for the issuance of an annual proclamation by the Governor to designate April 5 as Okur-Chung Neurodevelopmental Syndrome awareness day. State Administration and Regulatory Oversight. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act designating April 5 as Okur-Chung Neurodevelopmental Syndrome Awareness Day.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
Chapter 6 of the General Laws, as appearing in the 2020 Official Edition, is hereby amended by inserting after section 15ZZZZZZ, the following section:-
Section 15AAAAAAA. The governor shall annually issue a proclamation setting apart April 5 as Okur-Chung Neurodevelopmental Syndrome (OCNDS) Awareness Day, to raise awareness of this rare genetic disorder caused by heterozygous mutations in the CSNK2A1 gene on chromosome 20 and manifesting as developmental delay or differences in brain function, which can be managed with early therapy, and recommending that the day be observed in an appropriate manner by the people.